Synthorx to Present at Jefferies 2019 Healthcare Conference
May 29 2019 - 4:10PM
Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a
first-of-its-kind Expanded Genetic Alphabet platform technology to
discover and develop optimized biologics for cancer and autoimmune
disorders, today announced the Company will present at the
Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at
9:00 a.m. ET in New York, NY.
The live webcast of the company’s presentation will be available
at Synthorx’s investor relations website. An archived replay
will be available for 60 days following the presentation.
To receive Synthorx’s press releases and other investor
information, please visit the Investor Relations page of the
company’s website and register for email alerts.
About SynthorxSynthorx, Inc. is a biotechnology
company focused on prolonging and improving the lives of people
with cancer and autoimmune disorders. Synthorx’s proprietary,
first-of-its-kind Expanded Genetic Alphabet platform technology
expands the genetic code by adding a new DNA base pair and is
designed to create optimized biologics, referred to as Synthorins.
A Synthorin is a protein optimized through incorporation of novel
amino acids encoded by the new DNA base pair that enables
site-specific modifications, which enhance the pharmacological
properties of these therapeutics. The company’s lead product
candidate, THOR-707, a variant of IL-2, is in development in
multiple tumor types as a single agent and in combination with an
immune checkpoint inhibitor. The company was founded based on
important discoveries in Dr. Floyd Romesberg’s lab at The Scripps
Research Institute. Synthorx is headquartered in La Jolla, Calif.
For more information, visit www.synthorx.com.
Investor Relations Contacts: Enoch Kariuki,
Pharm.D.Synthorx, Inc.ekariuki@synthorx.com 858-750-4750
Christina TartagliaStern IR,
Inc.christina.tartaglia@sternir.com212-362-1200
Media Relations Contact:Lauren
FishCanale Communicationslauren@canalecomm.com619-849-5386
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Jul 2023 to Jul 2024